DISCONTINUED OPERATIONS (Revenues and Net Income (Loss)) (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Loss from discontinued operations	$ (1,173)	$ (723)
Discontinued operations | Genetic Assays and Platforms and Patient Testing
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Net sales	1,103	5,763
Cost of goods sold	1,183	3,074
Gross profit	(80)	2,689
Selling, general and administrative expense	1,025	3,250
Research and development expense	68	116
Loss from discontinued operations before income taxes	(1,173)	(677)
Income tax expense	0	46
Loss from discontinued operations	$ (1,173)	$ (723)